Observational studyNature communications2021

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC.

Bin Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.